Details
Stereochemistry | ACHIRAL |
Molecular Formula | C25H34N6O3 |
Molecular Weight | 466.5759 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCC1=NN(C)C2=C1NC(=NC2=O)C3=CC(=CC=C3OCC)C(=O)CN4CCN(CC)CC4
InChI
InChIKey=RRBRQNALHKQCAI-UHFFFAOYSA-N
InChI=1S/C25H34N6O3/c1-5-8-19-22-23(29(4)28-19)25(33)27-24(26-22)18-15-17(9-10-21(18)34-7-3)20(32)16-31-13-11-30(6-2)12-14-31/h9-10,15H,5-8,11-14,16H2,1-4H3,(H,26,27,33)
Molecular Formula | C25H34N6O3 |
Molecular Weight | 466.5759 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/17914141Curator's Comment: The description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/16901855 | https://www.ncbi.nlm.nih.gov/pubmed/18178354
Sources: https://www.ncbi.nlm.nih.gov/pubmed/17914141
Curator's Comment: The description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/16901855 | https://www.ncbi.nlm.nih.gov/pubmed/18178354
Acetildenafil is an analog of the phosphodiesterase inhibitor sildenafil, named for a substitution of an acetyl group for a sulfonyl group. This compound has been identified in herbal products marketed as aphrodisiacs. The physiological and toxicological properties of this analog have not been elucidated.
Originator
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL1827 Sources: https://www.ncbi.nlm.nih.gov/pubmed/18178354 |
7.6 nM [IC50] |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Unknown Approved UseUnknown |
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 10:00:06 GMT 2023
by
admin
on
Sat Dec 16 10:00:06 GMT 2023
|
Record UNII |
TP0E2BW57H
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WIKIPEDIA |
Designer-drugs-Acetildenafil
Created by
admin on Sat Dec 16 10:00:06 GMT 2023 , Edited by admin on Sat Dec 16 10:00:06 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
831217-01-7
Created by
admin on Sat Dec 16 10:00:06 GMT 2023 , Edited by admin on Sat Dec 16 10:00:06 GMT 2023
|
PRIMARY | |||
|
135566112
Created by
admin on Sat Dec 16 10:00:06 GMT 2023 , Edited by admin on Sat Dec 16 10:00:06 GMT 2023
|
PRIMARY | |||
|
TP0E2BW57H
Created by
admin on Sat Dec 16 10:00:06 GMT 2023 , Edited by admin on Sat Dec 16 10:00:06 GMT 2023
|
PRIMARY | |||
|
ACETILDENAFIL
Created by
admin on Sat Dec 16 10:00:06 GMT 2023 , Edited by admin on Sat Dec 16 10:00:06 GMT 2023
|
PRIMARY | |||
|
DTXSID10232178
Created by
admin on Sat Dec 16 10:00:06 GMT 2023 , Edited by admin on Sat Dec 16 10:00:06 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET -> INHIBITOR |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |